Corvia Medical (United States)

Recent papers from Corvia Medical (United States)

1. Type 2 diabetes in heart failure with preserved and mildly reduced ejection fraction: insights from the REDUCE-LAP-HF II trialESC Heart Failure · 2026
2. Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF IICirculation Population Health and Outcomes · 2026
3. Significant Suppression of Multiple Sclerosis in the Mouse EAE Model Using the PrC-210 AminothiolInternational Journal of Molecular Sciences · 2025
4. Validating the current duration approach for measuring infertility prevalence using novel app data from the USAHuman Reproduction · 2025
5. Epicardial adipose tissue, functional status and invasive hemodynamics in heart failure with preserved ejection fraction.JACC Advances · 2025
6. Management of Flow Reversal in Patients With Atrial Shunts Implanted to Reduce Left Atrial PressureJACC Case Reports · 2025
7. Device Therapy for Heart Failure With Preserved Ejection Fraction: The Problem, the Mechanism, the Device, the TrialCatheterization and Cardiovascular Interventions · 2025
8. Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsAmerican Heart Journal · 2024
9. Impact of Digital Health Interventions on Birth Equity: A ReviewSeminars in Reproductive Medicine · 2024
10. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionJAMA Cardiology · 2024
11. Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancerCancer Research · 2024
12. Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II TrialEuropean Journal of Heart Failure · 2023
13. Early intervention to prevent adverse child emotional and behavioural development following maternal depression in pregnancy: study protocol for a randomised controlled trialBMC Psychology · 2023
14. Left Atrial Enlargement is Associated with Pulmonary Vascular Disease in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure · 2023
15. Telemedicine utilization and perceived quality of virtual care among pregnant and postpartum women during the COVID-19 pandemicJournal of Telemedicine and Telecare · 2022
16. Feasibility of leveraging menstrual cycle tracking apps for preconception research recruitmentFrontiers in Reproductive Health · 2022
17. Update on Atrial Shunt Therapy for Treatment of Heart FailureStructural Heart · 2022
18. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeNew England Journal of Medicine · 2022
19. Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fractionJournal of International Medical Research · 2022
20. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart FailureCirculation · 2022